Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by robertshawon Mar 27, 2019 6:27am

91 Views

Post# 29540845

RE:RE:Also - Two Presentations by Dr. McFarland at Conference

vestor111 wrote: This research paper expands the research into US Clinical studies. The number of universities, researchers and medical centers involved with TLT/McFarland's research into Ru/Os PDCs is steadily growing. Biotech analysts and big pharma scouts will start to notice.

Roswell Park is not very far from Toronto.

30 June 2019

Novel metal-based photosensitizers for photodynamic therapy: exploratory study

Author(s): Lindsey Carlsen, Taylor Mandeville, Roswell Park Comprehensive Cancer Ctr. (United States); Patrick Barrett, Evan Bradner, Tariq Sainuddin, Sherri McFarland, The Univ. of North Carolina at Greensboro (United States); Sarah Chamberlain, David Bellnier, Gal Shafirstein, Roswell Park Comprehensive Cancer Ctr. (United States)